About the Company

Frontage Laboratories is a global full-service drug development outsourcing (CRO) company, founded in the United States in 2001, with its headquarters in Exton, west of Philadelphia, Pennsylvania. In 2006, Frontage Laboratories (Shanghai) Co., Ltd. was established, with branch offices and management teams in Suzhou and Zhengzhou. On May 30, 2019, Frontage Holdings (the listing entity of Frontage Laboratories) successfully listed on the Main Board of the Hong Kong Stock Exchange under the stock code 1521.HK.

Frontage Laboratories has always adhered to the principle of "Same Quality System in Both China and the United States," ensuring that data obtained can be used for global submissions. To date, it has provided high-quality, high-standard R&D services for new and generic drugs to over 400 clients worldwide. As a partner for the internationalization of Chinese pharmaceutical companies and high-end drug development, Frontage Laboratories boasts a skilled professional team, equipped with internationally advanced drug development instruments and equipment, and strives to create a friendly and relaxed cooperation and communication environment for clients. Focused on integrated professional services, its business scope includes bioanalysis, BE clinical services, CMC drug formulation development, cGMP consulting, and international drug registration services.

● We provide employees with comprehensive benefits and fulfill a full commitment to their health and well-being.
● We offer employees the opportunity to collaborate with top-tier pharmaceutical companies, making them key contributors to the drug development process.
● We provide excellent career development opportunities, ensuring employees continuously accumulate experience in the industry.
● Our employees are our most valuable asset, and we have a clear employee reward plan that acknowledges their dedication and rewards their hard work.

You may also send your resume to the recruitment mailbox: recruitment@*
For more information, please visit our company website: *

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

This company — Fortune 500? (More)

Yes, ranked in 中国高新技术企业慈善公益500强:

honors, qualifications & industry associations

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 435.505万(美元)
Legal Representative: SONG LI(李松)
Date Established:
Credit Code: 91310115778520189E
Registered Address: 中国(上海)自由贸易试验区李冰路67弄13号

Partners & Suppliers

为艾力斯提供生物分析服务,包括临床前及临床样品的药物浓度检测。 Source
合作客户 临床前研究服务(CRO)
采购动物模型用于BE和临床前试验 Source
供应商 CRO/CDMO企业客户

People who follow this company also follow

Competitors (Similar Companies)

医药 医药科技 医药工业
“The core platform of Sinopharm's Traditional Chinese Medicine industry”
仪器/仪表 传感器 光学元件 制冷
半导体 开关电源 直流/DC电源 测试仪器
烘焙 粽子 月饼 食品
医药 药物研发 新药研发 CRO
基因组学研究 体外诊断/IVD CRO 临床CRO
生物信息 生物信息学
医药 药物研发 仿制药 创新药
海外
单克隆抗体药物 试剂 医药 抗体
制造 研发 生产
冷冻面团 食品 生产 烘焙
“Professional services for the entire clinical trial process of drug pr”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates